ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,650Medicare Part D Prescriptions Filled, Including Refills

Rank: 278 out of 1000

$607K Total Retail Price of All Prescriptions

Rank: 190 out of 1000

637 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 637 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

30% of this provider’s 637 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 5,447 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 669 349 S3 1 1
ZOLPIDEM TARTRATE 344 170 2 16
LEVOTHYROXINE SODIUM 316 200 3 4
OMEPRAZOLE 314 178 4 2
MELOXICAM 278 168 5 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 236 126 6 20
SIMVASTATIN 225 160 7 3
TRAMADOL HCL 208 80 8 13
AMLODIPINE BESYLATE 201 125 9 6
METFORMIN HCL 192 121 10 8
ATENOLOL 183 126 11 24
LISINOPRIL 170 96 12 5
LEVOFLOXACIN 148 75 13 73
GABAPENTIN 143 60 14 11
PRAVASTATIN SODIUM 134 77 15 12
AZITHROMYCIN 131 74 16 36
TRIAMTERENE-HCTZ 115 77 17 48
CITALOPRAM HBR 114 41 18 17
PREDNISONE 112 61 19 42
METHOCARBAMOL 112 29 R 19 79
FUROSEMIDE 107 84 21 7
SULFAMETHOXAZOLE-TRIMETHOPRIM 107 59 21 70
POTASSIUM CHLORIDE 104 72 23 10
CYCLOBENZAPRINE HCL 96 43 R 24 39
HYDROCHLOROTHIAZIDE 95 57 25 9
FLUCONAZOLE 95 45 25 102
AMLODIPINE BESYLATE-BENAZEPRIL 81 62 27 59
GLIMEPIRIDE 77 42 28 34
NEXIUM 73 53 29 23
ALLOPURINOL 72 43 30 31
WARFARIN SODIUM 72 49 30 22
FLUOXETINE HCL 71 36 32 51
METOPROLOL TARTRATE 69 41 33 19
LOSARTAN POTASSIUM 68 52 34 25
CRESTOR 66 43 35 30
FLUTICASONE PROPIONATE 65 33 36 40
TAMSULOSIN HCL 65 55 36 33
BUPROPION XL 64 38 38 207
SERTRALINE HCL 63 32 39 26
LOSARTAN-HYDROCHLOROTHIAZIDE 62 28 40 38
CLOPIDOGREL 61 37 41 35
CIPROFLOXACIN HCL 59 37 42 46
ADVAIR DISKUS 56 50 43 65
GLIPIZIDE ER 56 32 43 106
CARVEDILOL 56 29 43 15
PROMETHAZINE HCL 55 0 R 46 54
PLAVIX 52 37 47 49
LYRICA 51 37 48 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.